At a meeting for investment analysts, Pfizer presented strategies to accelerate and refocus its pipeline and exploit new opportunities for global growth. “We have made real changes in how we operate our business — in our structure, culture and leadership — so that we have a much stronger foundation in place for pursuing the many opportunities before us,” said chairman and chief executive officer, Jeff Kindler. “We are delivering and accelerating our pipeline, and we will seize promising growth o...